Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank14
3Y CAGR+3.9%
5Y CAGR-40.6%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+3.9%/yr
vs -56.1%/yr prior
5Y CAGR
-40.6%/yr
Recent acceleration
Acceleration
+60.0pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.02M | -33.5% |
| 2024 | $3.04M | +363.0% |
| 2023 | $656000.00 | -63.5% |
| 2022 | $1.80M | -90.8% |
| 2021 | $19.62M | -28.4% |
| 2020 | $27.41M | -23.3% |
| 2019 | $35.74M | -26.0% |
| 2018 | $48.28M | +323.5% |
| 2017 | $11.40M | -6.4% |
| 2016 | $12.18M | - |